Directors & Officers

As of October 26, 2018

OutsideOutside Director

IndependentIndependent officer pursuant to Article 436-2 of the regulations of Tokyo Stock Exchange, Inc.

Representative Directors

Osamu Nagayama Representative Director & Chairman
Outside Director & Chairman of the Board of Directors of Sony Corporation
  • 1978 Joined the Company
  • 1985 Deputy General Manager of Development and Planning Div. and Director
  • 1987 Director & Senior Vice President
  • 1989 Representative Director & Deputy President
  • 1992 Representative Director, President & CEO
  • 2010 Outside Director & Chairman of the Board of Directors of Sony Corporation (to present)
  • 2012 Representative Director, Chairman & CEO
  • 2018 Representative Director & Chairman (to present)
Motoo Ueno Representative Director & Deputy Chairman
Executive Officer in charge of Corporate Social Responsibility, Risk Management, Compliance and Audit
  • 1984 Joined the Company
  • 1991 General Manager of London Representative Office
  • 1993 Director
  • 1994 Director and General Manager of Medical Information Div.
  • 1995 Director and General Manager of Clinical Research & Development Division
  • 1996 Director and Deputy General Manager of Research and Development Division
  • 1997 Director & Senior Vice President
  • 1998 Senior Vice President
  • 2000 Director & Senior Vice President
  • 2002 Director & Deputy President
  • 2003 Director & Deputy President, Vice President
  • 2004 Representative Director & Deputy President
  • 2006 Representative Director & President, Chugai Pharma Manufacturing Co., Ltd.
  • 2012 Representative Director & Deputy Chairman (to present)
Tatsuro Kosaka Representative Director, President & CEO
Outside Director of Asahi Group Holdings, Ltd.
  • 1976 Joined the Company
  • 1995 Deputy President of Chugai Pharma Europe Ltd. (U.K.)
  • 2000 General Manager of Business Strategy Planning Office
  • 2002 Vice President & General Manager of Corporate Planning Dept.
  • 2004 Senior Vice President & General Manager of Corporate Planning Dept.
  • 2005 Senior Vice President & Deputy Managing Director of Sales & Marketing Group, Senior Vice President & Head of Strategic Marketing Unit
  • 2008 Senior Vice President & Head of Lifecycle Management & Marketing Unit
  • 2010 Director & Executive Vice President
  • 2012 Representative Director, President & COO
  • 2016 Outside Director of Asahi Group Holdings, Ltd. (to present)
  • 2018 Representative Director, President & CEO (to present)

Directors

Outside Independent Yasuo Ikeda   Vice-Chairman of the Board of Directors, Musashi Academy of the Nezu Foundation, Specially Appointed Professor of Waseda University, Professor Emeritus of Keio University
  • 1979 Director of Keio University Hospital Blood Center
  • 1991 Professor of Internal Medicine of Keio University School of Medicine
  • 2001 Director of Keio University Center for Integrated Medical Research
  • 2005 Dean of Keio University School of Medicine
  • 2009 Professor Emeritus of Keio University (to present) Professor of Department of Life Science and Medical Bioscience of Graduate School of Advanced Science and Engineering of Faculty of Science and Engineering of Waseda University
  • 2010 Outside Director of the Company (to present)
  • 2013 Vice-Chairman of the Board of Directors, Musashi Academy of the Nezu Foundation (to present)
  • 2014 Specially Appointed Professor of Waseda University (to present)
Outside Independent Masayuki Oku Outside Director of Kao Corporation
Outside Director of Komatsu Ltd.
Outside Director of Panasonic Corporation
Outside Audit & Supervisory Board Member of Nankai Electric Railway Co., Ltd.
Non-Executive Director of The Bank of East Asia (China) Ltd.
  • 1968 Joined The Sumitomo Bank, Ltd. (SB)
  • 1994 Director, SB
  • 1998 Managing Director, SB
  • 1999 Managing Director and Managing Executive Officer, SB
  • 2001 Senior Managing Director and Senior Managing Executive Officer, SB, Senior Managing Director and Senior Managing Executive Officer of Sumitomo Mitsui Banking Corporation (SMBC)
  • 2002 Senior Managing Director of Sumitomo Mitsui Financial Group, Inc. (SMFG)
  • 2003 Deputy President, SMBC
  • 2005 Chairman, SMFG, President and Chief Executive Officer, SMBC
  • 2015 Outside Director of the Company (to present)
  • 2017 Honorary Advisor, SMFG (to present)
Outside Independent Yoichiro Ichimaru Senior Advisor of Aioi Nissay Dowa Insurance Co., Ltd.
  • 1971 Joined Toyota Motor Sales Co., Ltd.
  • 2001 Member of the Board of Directors of Toyota Motor Corporation (“TMC”)
  • 2003 Managing Executive Officer of TMC
  • 2005 Senior Managing Director of TMC
  • 2009 Representative Director, Executive Vice President of TMC
    Corporate Auditor of Aioi Insurance Co., Ltd.
  • 2010 Corporate Auditor of Aioi Nissay Dowa Insurance Co., Ltd.
  • 2011 Audit & Supervisory Board Member of TMC
  • 2015 Senior Advisor to the Board of TMC
    Representative Director, Chairman of Aioi Nissay Dowa Insurance Co., Ltd.
  • 2017 Outside Director of the Company (to present)
    Senior Advisor of Aioi Nissay Dowa Insurance Co., Ltd. (to present)
Christoph Franz Chairman of the Board of Directors of Roche Holding Ltd.
Member of the Board of Directors of Stadler Rail AG (Switzerland)
Member of the Board of Directors of Zurich Insurance Group Ltd. (Switzerland)
  • 1990 Joined Deutsche Lufthansa AG
  • 1994 Member of the Executive Board and CEO of Passenger Transport Division of Deutsche Bahn AG
  • 2004 CEO of Swiss International Air Lines AG
  • 2009 Deputy Chairman of the Executive Board of Deutsche Lufthansa AG
  • 2011 Chairman of the Executive Board and CEO of Deutsche Lufthansa AG
  • 2014 Chairman of the Board of Directors of Roche Holding Ltd. (to present)
  • 2017 Director of the Company (to present)
Daniel O’Day CEO of Roche Pharmaceuticals, Member of the Corporate Executive Committee, Member of the Genentech (USA) Board of Directors
  • 1987 Joined Roche Pharma USA
  • 1995 Director Human Resources, Roche Pharma U.S.A.
  • 1996 Director Product Marketing, Roche Pharma U.S.A.
  • 1998 Business Unit Head, Arthritis and Respiratory, Roche Pharma Headquarters
  • 1999 Lifecycle Leader Tamiflu, Roche Pharma Headquarters
  • 2001 Head Corporate Planning, Roche Pharma Japan
  • 2003 General Manager, Roche Pharma Denmark
  • 2006 President & CEO of Roche Molecular Diagnostics
  • 2010 COO Roche Diagnostics Division, Member of the Corporate Executive Committee
  • 2012 COO Roche Pharmaceuticals Division, Member of the Corporate Executive Committee, Member of the Genentech Board of Directors
  • 2013 Director of the Company (to present)
  • 2016 CEO Roche Pharmaceuticals, Member of the Corporate Executive Committee, Member of the Genentech Board of Directors (to present)
Sophie Kornowski-Bonnet Senior Partner, Gurnet Point Capital
  • 1985 Abbott Diagnostic Division – Paris – France, Scientific Manager
  • 1989 Abbott Pharmaceutical Products – Chicago, U.S.A., Marketing Research Analyst
  • 1990 Abbott Pharmaceutical Products – New York, U.S.A., Neuroscience Sales Representative
  • 1991 Sanofi Winthrop – New York, U.S.A., Director, Strategic Marketing, Diagnostic Imaging
  • 1994 Sanofi Winthrop – Paris, France, Director, Neuroscience Business Unit
  • 1996 Merck Sharp & Dohme Paris, France, Director, Marketing Research and Strategic Planning
  • 1997 Merck Sharp & Dohme Israel, Managing Director
  • 2000 Vice-President Arthritis and Analgesia Franchise, Merck & Co. Inc. U.S.A.
  • 2002 Merck Sharp & Dohme Paris, France, Director, Rheumatology Division
  • 2006 Merck Sharp & Dohme Paris, France, Director, Cardiovascular Division
  • 2007 Roche Pharma, France, General Manager
  • 2012 Head of Roche Partnering, Member of the Roche Enlarged Corporate Executive Committee
    Director of the Company (to present)
  • 2018 Senior Partner, Gurnet Point Capital (to present)

Audit & Supervisory Board Members

Shunji Yokoyama Audit & Supervisory Board Member (full-time)
  • 1981 Joined the Company
  • 2002 General Manager of Clinical Research Dept. 1
  • 2004 Vice President, General Manager of Clinical Research & Development Div.
  • 2007 Vice President, Deputy General Manager of Corporate Regulatory Compliance & Quality Assurance Div. and Head of Drug Safety Unit
  • 2009 Vice President, General Manager of Drug Safety Div.
  • 2011 Vice President, Head of Quality & Regulatory Compliance Unit and General Manager of Drug Safety Div.
  • 2013 Senior Vice President, Head of Regulatory & Quality Management Unit
  • 2015 Audit & Supervisory Board Member (full-time) (to present)
Mamoru Togashi Audit & Supervisory Board Member (full-time)
  • 1982 Joined the Company
  • 2004 President of Chugai Business Support Co., Ltd.
  • 2006 General Manager of Corporate Communications Dept.
  • 2009 General Manager of Human Resources Management Dept.
  • 2010 Vice President, General Manager of Human Resources Supervisory Div., Human Resources Management Dept.
  • 2016 Vice President, General Manager of Human Resources Supervisory Div.
  • 2017 Audit & Supervisory Board Member (full-time) (to present)
Outside Independent Hisashi Hara Advisor, The Law Office of Nagashima Ohno & Tsunematsu
Outside Director of the Board of Nippon Paint Holdings Co., Ltd.
  • 1975 Registered as an attorney-at-law (Dai-ichi Tokyo Bar Association)
  • 1975 Joined Nagashima & Ohno (currently, Nagashima, Ohno & Tsunematsu)
  • 1983 Partner of Nagashima & Ohno
  • 1991 Managing Partner of Nagashima & Ohno
  • 2006 Chairman of Nagashima, Ohno & Tsunematsu
  • 2006 Administrative Council Member of the University of Tokyo
  • 2008 Outside Corporate Auditor, JPMorgan Securities Japan Co., Ltd.
  • 2012 Outside Audit & Supervisory Board Member of the Company (to present)
  • 2013 General Representative of the Asia-Pacific region, The Law Office of Nagashima Ohno & Tsunematsu
  • 2018 Advisor, The Law Office of Nagashima Ohno & Tsunematsu (to present)
  •   Outside Director of the Board of Nippon Paint Holdings Co., Ltd. (to present)
Outside Independent Takaaki Nimura Representative of Nimura Certified Public Accountant Office
  • 1974 Joined Arthur Young & Co., Tokyo Office
  • 1980 Seconded to Asahi & Co., Osaka Office
  • 1983 Seconded to Arthur Young & Co., Los Angeles Office
  • 1989 Partner of Asahi Shinwa & Co.
  • 1993 Joined Showa Ota & Co.
  • 1997 Senior partner of Showa Ota & Co.
  • 2008 Executive Board Member of Ernst & Young ShinNihon LLC
  • 2010 Established Nimura Certified Public Accountant Office
  • 2012 Director of Sony Corporation
  • 2016 Outside Audit & Supervisory Board Member of the Company (to present)

Executive Officers

Shinya Unno
Executive Vice President
In charge of Human Resources Management, Human Capital Development, Legal, General Affairs and Secretarial and General Manager of Human Resources Supervisory Div., in charge of General Affairs Dept. and Secretarial Dept.
Yasushi Ito
Executive Vice President
In charge of Project & Lifecycle Management (R&D), Regulatory & Quality Management, Clinical Development, Drug Safety and Medical Affairs and Co-Head of Project & Lifecycle Management Unit
Osamu Okuda
Executive Vice President
In charge of Project & Lifecycle Management (Marketing), Foundation Medicine and Corporate Planning and Co-Head of Project & Lifecycle Management Unit
Hisafumi Okabe
Executive Vice President
In charge of Research and Translational Clinical Research and General Manager of Translational Clinical Research Div.
Toshiaki Itagaki
Executive Vice President, CFO
In charge of Finance & Accounting, Corporate Communication, Information System and Purchasing and General Manager of Finance Supervisory Div., General Manager of IT Supervisory Div. and General Manager of Finance & Accounting Dept.
Susumu Kato
Senior Vice President
Special Mission for CEO
Keiji Kono
Senior Vice President
In charge of External Affairs Dept. and Global Health Policy
Junichi Ebihara
Senior Vice President
General Manager of Legal Dept.
Yoshiaki Ohashi
Senior Vice President
Head of Quality & Regulatory Compliance Unit and General Manager of Drug Safety Div.
Tetsuya Yamaguchi
Vice President
Department Manager of Business Development Dept.
Toshihiko Komori
Vice President
In charge of Intellectual Property Dept., Project & Lifecycle Management Unit
Hisanori Takanashi
Vice President
General Manager of Clinical Development Div.
Hiroshi Murata
Vice President
General Manager of Pharmaceutical Technology Div.
Shinji Hidaka
Vice President
General Manager of Medical Affairs Div.
Tsunanori Sato
Vice President
General Manager of Marketing & Sales Div.
Kouichi Nishikawa
Vice President
Deputy General Manager of Marketing & Sales Div. (Overseas Business) & General Manager of Overseas Business Dept.
Hiroyuki Matsumoto
Vice President
Head of Kanto-Minami Regional Management Office, Marketing & Sales Div.
Minoru Watanabe
Vice President
General Manager of Corporate Planning Dept. and Head of Foundation Medicine Unit
  • Like
  • Tweet
  • LINE it!
  • E-mail

Company Outline

Back to top